Advancing pharmacometrics and systems pharmacology
- PMID: 23085873
- PMCID: PMC5540435
- DOI: 10.1038/clpt.2012.151
Advancing pharmacometrics and systems pharmacology
Abstract
Pharmacometrics and systems pharmacology are emerging as principal quantitative sciences within drug development and experimental therapeutics. In recognition of the importance of pharmacometrics and systems pharmacology to the discipline of clinical pharmacology, the American Society for Clinical Pharmacology and Therapeutics (ASCPT), in collaboration with Nature Publishing Group and Clinical Pharmacology & Therapeutics, has established CPT: Pharmacometrics & Systems Pharmacology to inform the field and shape the discipline.
Conflict of interest statement
Similar articles
-
ASCPT Task Force for advancing pharmacometrics and integration into drug development.Clin Pharmacol Ther. 2010 Aug;88(2):158-61. doi: 10.1038/clpt.2010.141. Clin Pharmacol Ther. 2010. PMID: 20648032 Review.
-
Clinical Pharmacology & Therapeutics: the next five years.Clin Pharmacol Ther. 2015 Jan;97(1):2-6. doi: 10.1002/cpt.22. Epub 2014 Dec 5. Clin Pharmacol Ther. 2015. PMID: 25670374 Free PMC article.
-
Pharmacometrics and Systems Pharmacology 2030.Clin Pharmacol Ther. 2020 Jan;107(1):76-78. doi: 10.1002/cpt.1683. Epub 2019 Nov 23. Clin Pharmacol Ther. 2020. PMID: 31758700
-
CPT: Pharmacometrics and Systems Pharmacology.CPT Pharmacometrics Syst Pharmacol. 2012 Sep 26;1(9):e8. doi: 10.1038/psp.2012.8. CPT Pharmacometrics Syst Pharmacol. 2012. PMID: 23835888 Free PMC article.
-
Systems biology, connectivity and the future of medicine.Syst Biol (Stevenage). 2005 Dec;152(4):174-8. doi: 10.1049/ip-syb:20050034. Syst Biol (Stevenage). 2005. PMID: 16986257 Review.
Cited by
-
Systems approaches evolve clinical pharmacology.CPT Pharmacometrics Syst Pharmacol. 2013 Aug 21;2(8):e68. doi: 10.1038/psp.2013.48. CPT Pharmacometrics Syst Pharmacol. 2013. PMID: 23965784 Free PMC article. No abstract available.
-
How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion.Front Pharmacol. 2014 Oct 31;5:231. doi: 10.3389/fphar.2014.00231. eCollection 2014. Front Pharmacol. 2014. PMID: 25400580 Free PMC article. Review.
-
Companion diagnostics at the intersection of personalized medicine and healthcare delivery.Biomark Med. 2015;9(1):1-3. doi: 10.2217/bmm.14.99. Biomark Med. 2015. PMID: 25605449 Free PMC article. No abstract available.
-
Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.Front Pharmacol. 2017 Mar 27;8:155. doi: 10.3389/fphar.2017.00155. eCollection 2017. Front Pharmacol. 2017. PMID: 28396636 Free PMC article.
References
-
- Atkinson AJ, Jr, Lyster PM. Systems clinical pharmacology. Clin Pharmacol Ther. 2010;88:3–6. - PubMed
-
- Atkinson AJ, Jr, Smith BP. Models of physiology and physiologically based models in clinical pharmacology. Clin Pharmacol Ther. 2012;92:3–6. - PubMed
-
- Grasela TH, Slusser R. Improving productivity with model-based drug development: an enterprise perspective. Clin Pharmacol Ther. 2010;88:263–268. - PubMed
-
- Kohl P, Crampin EJ, Quinn TA, Noble D. Systems biology: an approach. Clin Pharmacol Ther. 2010;88:25–33. - PubMed
-
- Arrell DK, Terzic A. Network systems biology for drug discovery. Clin Pharmacol Ther. 2010;88:120–125. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources